{ "tag": [ "compiled" ], "id": "ocds-r6ebe6-0000455625-2016-12-15T00:00:00Z", "date": "2016-12-15T00:00:00Z", "ocid": "ocds-r6ebe6-0000455625", "initiationType": "tender", "parties": [ { "id": "org-23", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "David Brycce", "email": "davidbryce@nhs.net", "telephone": "+44 1698794512", "url": "http://" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } } ], "buyer": { "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "id": "org-23" }, "tender": { "id": "NP601/16", "title": "Cardiology Stents", "description": "The Common Services Agency (more commonly known as National Services Scotland) ('the Authority') acting through its division Procurement, Commissioning & Facilities is undertaking this procurement of the supply and delivery of Cardiology Stents for use in Percutaneous Coronary Intervention procedures (Angioplasty) and related service and support ('Products') on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as 'Participating Authorities')", "status": "complete", "items": [ { "id": "3", "additionalClassifications": [ { "id": "33182300", "scheme": "CPV" } ], "deliveryAddresses": [ { "region": "UKM" } ], "relatedLot": "3" }, { "id": "1", "additionalClassifications": [ { "id": "33182300", "scheme": "CPV" } ], "deliveryAddresses": [ { "region": "UKM" } ], "relatedLot": "1" }, { "id": "2", "additionalClassifications": [ { "id": "33182300", "scheme": "CPV" } ], "deliveryAddresses": [ { "region": "UKM" } ], "relatedLot": "2" } ], "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "goods", "documents": [ { "id": "DEC267254", "documentType": "awardNotice", "title": "Cardiology Stents", "description": "The Common Services Agency (more commonly known as National Services Scotland) ('the Authority') acting through its division Procurement, Commissioning & Facilities is undertaking this procurement of the supply and delivery of Cardiology Stents for use in Percutaneous Coronary Intervention procedures (Angioplasty) and related service and support ('Products') on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as 'Participating Authorities')", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC267254", "format": "text/html" } ], "lots": [ { "id": "3", "title": "Bioresorbable Stents", "description": "This requirement is for Bioresorbable Stents- stents which once deployed, dissolve over time to leave no material within the artery.", "status": "complete", "hasOptions": false }, { "id": "1", "title": "Drug Eluting & Bare Metal Stents", "description": "This requirement is for \"workhorse\" Drug Eluting Stents and Bare Metal Stents for use in the majority of PCI cases. This requirement will include a range of stents with variable diameter and length, suitable for the majority of PCI cases.", "status": "complete", "hasOptions": false }, { "id": "2", "title": "Innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug (for the purpose of anti dual platelet therapy reduction)", "description": "This requirement is for innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug for the purpose of anti dual platelet therapy reduction. These stents would not be currently used for the majority of PCI cases.", "status": "complete", "hasOptions": false } ], "coveredBy": [ "GPA" ], "techniques": { "hasFrameworkAgreement": true }, "classification": { "id": "33182300", "scheme": "CPV" }, "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection process has previously been made) applied to be selected to tender, of its decision to award the Framework Agreement which notification will contain, among other information, a summary of the reasons as to why the economic operator was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 (ten) clear calendar days (or a minimum of 15 (fifteen) if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages." }, "awards": [ { "id": "NP601/16-1", "title": "Innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug (for the purpose of anti dual platelet therapy reduction)", "relatedLots": [ "2" ] }, { "id": "NP601/16-2", "title": "Bioresorbable Stents", "relatedLots": [ "3" ] }, { "id": "NP601/16-3", "title": "Drug Eluting & Bare Metal Stents", "relatedLots": [ "1" ] } ], "contracts": [ { "id": "NP601/16-1", "awardID": "NP601/16-1", "title": "Innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug (for the purpose of anti dual platelet therapy reduction)", "status": "active", "dateSigned": "2016-12-06T00:00:00Z" }, { "id": "NP601/16-2", "awardID": "NP601/16-2", "title": "Bioresorbable Stents", "status": "active", "dateSigned": "2016-12-06T00:00:00Z" }, { "id": "NP601/16-3", "awardID": "NP601/16-3", "title": "Drug Eluting & Bare Metal Stents", "status": "active", "dateSigned": "2016-12-06T00:00:00Z" } ], "language": "EN", "relatedProcesses": [ { "id": "1", "relationship": [ "planning" ], "scheme": "EU-OJ", "identifier": "2016/S 156-282291" } ], "description": "(SC Ref:474763)", "links": [ { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000455625" } ], "noticetype": "OJEU - F3 - Contract Award Notice" }